#Black #Patients Aren’t Avoiding #ClinicalTrials.
They Often Aren’t Asked

#Black #Patients Aren’t Avoiding #ClinicalTrials.
They Often Aren’t Asked
We’re seeing this firsthand with our own research pharmacy customers, who are beginning to challenge the traditional “locked rate for the life of the study” model in favor of annual adjustments.
How are other research teams approaching this?
Discover the latest advances in breast, lung & prostate cancer care! Join the Alliance for a free public webinar on Oct 1 featuring leading researchers & patient advocates sharing key findings from #ASCO26. Register now: bit.ly/Alliance-Webinar-Oct26 #clinicaltrials
Did you know that most #ClinicalTrials don't use #placebos alone? When an effective treatment already exists, participants usually receive the current standard of care along with a potential new treatment—not a placebo. Learn more about clinical trial safety: https://bit.ly/4Aj6NKK
🧬 Moderna $MRNA surged 14%+ after positive Phase 3 cancer-vaccine results, marking a major milestone for its mRNA-based cancer therapy and helping drive a gain of 400%+ over the past year.
Translation and linguistic validation can affect when and where a #COA is implemented.
Join our webinar to learn how to plan for these requirements before they create operational challenges or study delays: https://ow.ly/T7Oi50ZIyu2
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TVbXz1 !
A companion guide highlights six areas where Exagen supports trials. Read full article: go.exagen.com/ApkOaaR
#AutoimmuneDisease #ClinicalTrials #Biomarkers #Biopharma #TranslationalMedicine #DrugDevelopment
Two weeks until the SIOG Webinar on including older adults in cancer research. 24 September at 16:00 CEST. Free, open to all.
Register: https://loom.ly/Cq_unEI
#GeriatricOncology #GeriOnc #ClinicalTrials
A question on #BrainCancer #ClinicalTrials tabled by Lizzi Collinge on 11-09-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-09-11/29273
Attending #EANO26?
Come join Dr. Andreas Hottinger at 18:00 on Sep. 24th at the Theatre Studio.
Dr. Hottinger will present on the #braintumor trial finder and the impact we've made in 1 year.
Link to tool - www.braintumortrialfinder.org
Hope to see you there!
#clinicaltrials #neurooncology
A new ovarian cancer trial is testing a different way to harness the immune system. NTB-928 is designed to redirect a patient’s own T cells to recognise and attack cancer cells.
📣 Fresh off the press: the latest EASY-AS Monthly Newsletter (August 2026 Edition)
@leicesterctu.bsky.social @thebhf.bsky.social
#AorticStenosis #Cardiology #ClinicalTrials #ClinicalResearch #TrialUpdates #MustRead #ReadAllAboutIt #HappyReading #InCaseYouMissedIt #News #August2026
New clinical trial
Evaluation of an Online, On Demand Multimodal Wellness Program to Reduce Fatigue and Improve Quality of Life in Progressive Multiple Sclerosis: A Randomized Waitlist Controlled Trial (DEW Study)
New clinical trial
ASSOCIATION BETWEEN PERIPHERAL IMMUNE BIOMARKERS AND FUNCTIONAL PERFORMANCE IN PATIENTS WITH MULTIPLE SCLEROSIS
"Join us at IGCS 2026 for this in-person Industry Supported Symposium!
🎟️ Register for the Annual Global Meeting today: https://ow.ly/Nsru50ZNCTz
#ClinicalTrials #GynecologicOncology #GOGPartners #GOGF #IGCS2026 #GCAM #IWishIKnew"
Neo Mokoena on a 6,000-person heart failure trial asking whether finerenone helps only by lowering blood pressure.
healthsciencereviews.com/2026/09/21/f...
#SciComm #Cardiology #HeartFailure #ClinicalTrials #UCT #HealthSciences #BMedSci
🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVZrrx
@ASCO
#SocialListening #LucidQuest
New clinical trial
Exploring Reproductive Decision-Making Among Women With Multiple Sclerosis in Assiut Governorate: Mixed-Methods Study